Physician profile
Purnendu Gupta
NPI 1740358308
$32,555.57
in general payments reported to CMS, 2019-2025
10 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,323 · 2020: $1,927 · 2021: $1,240 · 2022: $14K · 2023: $1,275 · 2024: $9,640 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,091 · Travel and Lodging: $2,076 · Food and Beverage: $1,337 · Education: $819 · Entertainment: $23.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,090.64 |
| Travel and Lodging | $2,076.38 |
| Food and Beverage | $1,337.25 |
| Education | $818.72 |
| Entertainment | $23.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $26,105.46 | 2019-2024 | Expedium, Viper, Conduit |
| Zimvie INC. | $2,394.11 | 2022-2023 | |
| Depuy Synthes Products, INC. | $1,755.00 | 2020 | |
| Depuy Synthes Sales INC. | $1,732.99 | 2019-2025 | Expedium, Trialtis, Altalyne |
| Orthopediatrics Corp. | $237.34 | 2023-2025 | |
| Nuvasive, INC. | $189.90 | 2021 | |
| Zimmer Biomet Holdings, INC. | $92.45 | 2019 | |
| Argentum Medical | $23.63 | 2024 | |
| Calliditas Therapeutics US INC. | $13.19 | 2022 | |
| Biomarin Pharmaceutical INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Purnendu Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.